Skip to main content
. 2017 Dec 26;9(15):12418–12431. doi: 10.18632/oncotarget.23811

Table 1. Comparison of demographics and history of comorbidity between ACOS and non-ACOS cohorts.

ACOS
No (N = 20513) Yes (N = 10260)
Variable n % n % p-value
Sex 0.99
 Female 8826 43.0 4414 43.0
 Male 11687 57.0 5846 57.0
Age, year 0.99
 40–49 2470 12.0 1235 12.0
 50–64 6736 32.8 3368 32.8
 ≥65 11307 55.1 5657 55.1
 Mean (SD)# 65.5 11.9 65.6 11.8 0.38
Comorbidity
 Diabetes 4019 19.6 2425 23.6 < .0001
 Hypertension 9659 47.1 6254 61.0 < .0001
 Hyperlipidemia 5065 24.7 3271 31.9 < .0001
 Coronary artery disease 5044 24.6 4065 39.6 < .0001
 Alcohol-related illness 469 2.29 494 4.81 < .0001
 Sleep disorder 3659 17.8 3063 29.9 < .0001
 Anxiety 1371 6.68 1223 11.9 < .0001
 Atopic related diseases 5586 27.2 4739 46.2 < .0001
 Cancer 756 3.69 396 3.86 0.45
 Tuberculosis 466 2.27 782 7.62 < .0001
 Pneumonia 1005 4.90 1785 17.4 < 0.001
Medicine
 Inhaled corticosteroids (ICSs) 652 3.18 2722 26.5 < .0001
 Oral steroids(OSs) 8243 40.2 7941 77.4 < .0001

ACOS, asthma–COPD overlap syndrome; Chi-square test; #Student’s t-test.